Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005.

Diabetes & Metabolism Journal
Myung Ha LeeIl Suh

Abstract

Dyslipidemia is a disorder of lipid metabolism, including elevated total cholesterol, elevated triglyceride, elevated low density lipoprotein cholesterol (LDL-C), and decreased high density lipoprotein cholesterol (HDL-C). The objective of this study was to investigate recent changes in the prevalence of dyslipidemia and also the rates of awareness, treatment, and control of dyslipidemia among Korean adults. Dyslipidemia is defined according to the National Cholesterol Education Program-Adult Treatment Panel III as total cholesterol ≥240 mg/dL, LDL-C ≥160 mg/dL, HDL-C <40 mg/dL, and triglyceride ≥200 mg/dL. The prevalence of dyslipidemia was estimated for adults aged ≥20 years using the Korea National Health and Nutrition Survey (KNHANES) in 1998 (n=6,923), 2001 (n=4,882), and 2005 (n=5,323). Rates of awareness, treatment and control of dyslipidemia were calculated for adults aged ≥30 years using the KNHANES in 2005 (n=4,654). The prevalence of dyslipidemia (aged ≥20 years) increased from 32.4% in 1998 to 42.6% in 2001 and 44.1% in 2005. Compared with the KNHANES in 1998, the prevalence of dyslipidemia was 47% (95% confidence interval [CI], 35% to 59%) higher in 2001 and 61% (95% CI, 49% to 75%) higher in 2005. In 2005, only 9....Continue Reading

References

Nov 1, 1990·Maturitas·J JensenC Christiansen
Aug 1, 1986·American Heart Journal·W P Castelli
Mar 1, 1997·Mayo Clinic Proceedings·T O'Brien, T T Nguyen
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 9, 2005·Journal of Atherosclerosis and Thrombosis·Hidenori AraiToru Kita
Oct 13, 2005·JAMA : the Journal of the American Medical Association·Margaret D CarrollClifford L Johnson
Jun 20, 2008·International Journal of Clinical Practice·P P Toth
Aug 14, 2009·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Seung-Ji LimHye Young Kang

❮ Previous
Next ❯

Citations

Jan 28, 2014·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Sergio Martinez-HervasElena Bordiú
Sep 22, 2012·The Canadian Journal of Cardiology·Ross D Feldman, Tavis S Campbell
Jun 25, 2015·Japan Journal of Nursing Science : JJNS·Young Ko, Sunjoo Boo
Mar 18, 2015·Thyroid : Official Journal of the American Thyroid Association·Meng ZhaoJiajun Zhao
Jul 26, 2014·Pediatric Gastroenterology, Hepatology & Nutrition·Jung Min Yoon
Dec 18, 2013·Korean journal of family medicine·Hae-Joon LeeDong Wook Shin
Mar 26, 2016·Korean Circulation Journal·Seung Hwan HanKwang Kon Koh
Mar 27, 2015·Korean Circulation Journal·Ji Hye ParkHyeon Chang Kim
Jan 10, 2014·Diabetes & Metabolism Journal·Eun RohUNKNOWN Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association
Mar 1, 2013·Annals of Pediatric Endocrinology & Metabolism·Jung Sub Lim
Feb 6, 2015·Annals of Pediatric Endocrinology & Metabolism·Shin-Hee KimByoung Kyu Suh
Nov 23, 2017·The World Journal of Men's Health·Abolfazl MohammadbeigiHossein Ansari
Aug 23, 2018·European Journal of Clinical Nutrition·Doo Woong LeeEun-Cheol Park
Oct 26, 2018·F1000Research·Marcos Palacio RojasJoselyn Rojas
Sep 9, 2017·Diabetes/metabolism Research and Reviews·Junmei ZhouMing Zhang
Sep 6, 2020·The Science of the Total Environment·Kaihua ZhangYuming Guo
Jan 25, 2021·Oral Diseases·Isaac Suzart Gomes-FilhoAna Claudia Morais Godoy Figueiredo

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.